For the Inventor, By the Inventor

Enter assignee name

Redwood City, CA, United States of America

Maxygen, Inc.

USPTO Granted Patents = 124

% Expired Patents = 28.2

CIPO Patents = 2

EPO Patents = 5

Forward Citations = 17,265

Loading Chart...

Loading Chart...

98 inventors (with patents filed for the assignee):

Willem P C Stemmer (70 out of 90 patents)

Phillip A Patten (54 out of 100 patents)

Jeremy S Minshull (38 out of 126 patents)

4. Jon Edward Ness (20 out of 42 patents)

5. Claes Gustafsson (19 out of 44 patents)

6. Matthew B Tobin (16 out of 24 patents)

7. Steven Henry Bass (15 out of 31 patents)

8. Torben Lauesgaard Nissen (13 out of 19 patents)

9. Mark D Welch (13 out of 40 patents)

10. Andreas Crameri (12 out of 23 patents)

11. Sridhar Viswanathan (12 out of 13 patents)

12. Sridhar Govindarajan (11 out of 39 patents)

13. Linda A Castle (10 out of 39 patents)

14. Juha Punnonen (10 out of 30 patents)

15. Lorraine Joan Giver (8 out of 42 patents)

Core Competencies:

Antibody Diversity

Polypeptide Engineering

Cellular Engineering

Metabolic Engineering

Cytokine Polypeptides

Recombination

DNA Shuffling

Oligonucleotide Libraries

Evolved Variants

Co-Stimulatory Molecules

High Throughput Screening

Genetic Vaccines

124 patents: Sort by Forward Citations

1. 8252727 - Antibody diversity generation (2012-08-28),

2. 7795030 - Methods and compositions for cellular and metabolic engineering (2010-09-14),

3. 7783428 - Methods, systems, and software for identifying functional biomolecules (2010-08-24),

4. 7776598 - Methods and compositions for polypeptide engineering (2010-08-17),

5. 7751986 - Methods, systems, and software for identifying functional biomolecules (2010-07-06),

6. 7747393 - Methods, systems, and software for identifying functional biomolecules (2010-06-29),

7. 7747391 - Methods, systems, and software for identifying functional biomolecules (2010-06-29),

8. 7702464 - Method and apparatus for codon determining (2010-04-20),

9. 7696153 - G-CSF conjugates (2010-04-13),

10. 7629170 - Evolution of whole cells and organisms by recursive sequence recombination (2009-12-08),

11. 7620502 - Methods for identifying sets of oligonucleotides for use in an in vitro recombination procedure (2009-11-17),

12. 7620500 - Optimization of crossover points for directed evolution (2009-11-17),

13. 7619067 - Evolved interferon-alpha polypeptides (2009-11-17),

14. 7612170 - Co-stimulatory polypeptides (2009-11-03),

15. 7605115 - Subtilisin variants (2009-10-20),

Maxygen, Inc., based in Redwood City, California, specializes in polypeptide engineering, focusing on the development of innovative biopharmaceuticals. The company leverages advanced techniques in antibody diversity, cellular and metabolic engineering, and cytokine polypeptides to create novel therapeutic solutions. With a strong emphasis on recombination and DNA shuffling, Maxygen aims to enhance the efficacy and specificity of biologics, contributing to advancements in the biotechnology sector and improving patient outcomes.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

124 Patents

#20 in Redwood City, CA

#707 in California

#3,124 in US

#6,452 in the World

Redwood City, CA, United States of America

Maxygen, Inc.

Forward Citations = 17,265

98 inventors:

Willem P C Stemmer (70 out of 90 patents)

Phillip A Patten (54 out of 100 patents)

Jeremy S Minshull (38 out of 126 patents)

4. Jon Edward Ness (20 out of 42 patents)

5. Claes Gustafsson (19 out of 44 patents)

Please report any incorrect information to [email protected]

Loading…